Abstract
Is a genotype-guided therapy the optimal strategy to personalize anti-thrombotic management in patients with acute coronary syndrome?
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1093/eurheartj/ehac219
Copy DOIJournal: European heart journal | Publication Date: Jun 9, 2022 |
Citations: 2 |
Is a genotype-guided therapy the optimal strategy to personalize anti-thrombotic management in patients with acute coronary syndrome?
Join us for a 30 min session where you can share your feedback and ask us any queries you have